​

Forte Biosciences Ownership | Who Owns Forte Biosciences?

OverviewForecastFinancialsChart

Forte Biosciences Ownership Summary

Forte Biosciences is owned by 41.38% institutional investors, 10.96% insiders, and 47.66% retail investors. Fred alger management is the largest institutional shareholder, holding 14.20% of FBRX shares. Federated Hermes Kaufmann R is the top mutual fund, with 5.14% of its assets in Forte Biosciences shares.

FBRX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockForte Biosciences41.38%10.96%47.66%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fred alger management1.62M14.20%$20.93M
Orbimed advisors1.20M10.50%$15.48M
Tybourne capital management (hk)786.65K6.90%$10.17M
Bvf inc/il588.34K5.16%$7.61M
Cable car capital500.00K4.39%$6.46M
Sphera funds management495.11K4.34%$6.40M
Ikarian capital476.44K4.18%$6.16M
Adage capital partners gp333.33K2.92%$4.31M
Heights capital management143.03K1.25%$1.85M
Geode capital management346.29K0.75%$186.01K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tybourne capital management (hk)786.65K29.45%$10.17M
Cable car capital500.00K2.07%$6.46M
Sphera funds management495.11K1.50%$6.40M
Ikarian capital476.44K1.18%$6.16M
Heights capital management143.03K0.49%$1.85M
Orbimed advisors1.20M0.39%$15.48M
Bvf inc/il588.34K0.27%$7.61M
Fred alger management1.62M0.09%$20.93M
Perceptive advisors68.19K0.03%$881.72K
Quest partners16.90K0.02%$218.48K

Top Buyers

HolderShares% AssetsChange
Fred alger management1.62M0.09%708.04K
Orbimed advisors1.20M0.39%603.87K
Sphera funds management495.11K1.50%495.11K
Adage capital partners gp333.33K0.01%333.33K
Cable car capital500.00K2.07%280.40K

Top Sellers

HolderShares% AssetsChange
Bml capital management---1.76M
Vanguard group---665.23K
Adar1 capital management---159.26K
Renaissance---133.40K
Ikarian capital476.44K1.18%-132.78K

New Positions

HolderShares% AssetsChangeValue
Sphera funds management495.11K1.50%495.11K$6.40M
Adage capital partners gp333.33K0.01%333.33K$4.31M
Heights capital management143.03K0.49%143.03K$1.85M
Susquehanna group, llp34.34K-34.34K$18.44K
Envestnet asset management18.86K0.00%18.86K$243.81K

Sold Out

HolderChange
Jpmorgan chase-3.00
Qube research-3.00
Fmr-128.00
Loring wolcott & coolidge fiduciary advisors llp/ma-193.00
Wells fargo & company/mn-253.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024333.13%19,068,3950.10%411.14%1042.86%620.00%
Mar 31, 202432-8.57%19,048,5370.98%602.43%7-30.00%5-
Dec 31, 2023359.38%18,863,22512.96%490.79%10-28.57%5-28.57%
Sep 30, 2023323.23%16,699,693381.91%7929.16%1427.27%7-12.50%
Jun 30, 2023313.33%3,465,339-10.35%164.87%1137.50%8-11.11%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Federated Hermes Kaufmann R628.21K5.14%628.21K
Federated Hermes Kaufmann Growth628.21K5.14%628.21K
Federated Hermes Kaufmann Small Cap A426.49K3.49%426.49K
Federated Hermes Kaufmann Small Cap Grow426.49K3.49%426.49K
Vanguard Total Stock Mkt Idx Inv380.08K3.11%216.08K
Alger LIfe Sciences Innovation Composite178.34K1.46%-27.03K
Alger Small Cap Focus I176.87K1.45%176.87K
Alger Small Cap Focus Composite176.87K1.45%176.87K
Alger Small Cap Growth B157.75K1.29%-
Alger Health Sciences A134.57K1.10%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 21, 2024Riley Antony A CHIEF FINANCIAL OFFICERBuy$125.00K
Dec 18, 2023Wagner Paul A. See RemarksBuy$7.53K
Dec 13, 2023Wagner Paul A. See RemarksBuy$7.35K
Dec 14, 2023Wagner Paul A. See RemarksBuy$7.20K
Dec 11, 2023Wagner Paul A. See RemarksBuy$16.19K

Insider Transactions Trends

DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q41-
2024 Q3--

FBRX Ownership FAQ

Who Owns Forte Biosciences?

Forte Biosciences shareholders are primarily institutional investors at 41.38%, followed by 10.96% insiders and 47.66% retail investors. The average institutional ownership in Forte Biosciences's industry, Biotech Stocks , is 64.05%, which Forte Biosciences falls below.

Who owns the most shares of Forte Biosciences?

Forte Biosciences’s largest shareholders are Fred alger management (1.62M shares, 14.20%), Orbimed advisors (1.2M shares, 10.50%), and Tybourne capital management (hk) (786.65K shares, 6.90%). Together, they hold 31.60% of Forte Biosciences’s total shares outstanding.

Does Blackrock own Forte Biosciences?

BlackRock is not among the top 10 institutional shareholders of Forte Biosciences.

Who is Forte Biosciences’s biggest shareholder by percentage of total assets invested?

Tybourne capital management (hk) is Forte Biosciences’s biggest shareholder by percentage of total assets invested, with 29.45% of its assets in 786.65K Forte Biosciences shares, valued at 10.17M$.

Who is the top mutual fund holder of Forte Biosciences shares?

Federated Hermes Kaufmann R is the top mutual fund holder of Forte Biosciences shares, with 5.14% of its total shares outstanding invested in 628.21K Forte Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools